Clinical Trial

A Study in Healthy People to Test How Itraconazole Influences the Amount of BI 3031185 in the Blood

Completed Phase 1
View on ClinicalTrials.gov →
Summary
The main objective of this trial is to investigate the effect of multiple oral doses of the strong CYP3A4 inhibitor itraconazole on the pharmacokinetics of a single dose of BI 3031185 following oral administration.
Protocol Amendment History 5 amendments
This ClinicalTrials.gov record has been amended 5 times since 2025-10-02; most recent amendment 2026-02-02.
Status change: Active, Not Recruiting → Completed 2026-02-02
Status change: Recruiting → Active, Not Recruiting 2025-12-19
Status change: Not Yet Recruiting → Recruiting 2025-10-23
Trial Details
NCT Number NCT07211425
Lead Sponsor Boehringer Ingelheim
Conditions Healthy
Enrollment 14 participants
Start Date 2025-10-08
Primary Completion 2026-01-21 (estimated)
Study Completion 2026-01-21 (estimated)
Updated on ClinicalTrials.gov 2026-02-04